Dabur India enters into agreements for commercialization of Ayush 64, Ayush 82

22 Feb 2016 Evaluate

Dabur India has entered into License Agreements with the government for commercialization of malaria and diabetes drug Ayush 64 and Ayush 82 respectively. Ayush-64 is an ayurvedic formulation for treatment of Malaria and while Ayush-82 is for management of diabetes.

The agreement was signed between the National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology and the company.

Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.



Dabur India Share Price

509.80 1.75 (0.34%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2339.00
Godrej Consumer Prod 1135.80
Dabur India 509.80
Colgate Palmol. (I) 2164.75
P&G Hygiene 12583.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×